CytoSorbents CTSO 深 滬
已收盤 08-15 16:00:00 美东时间
1.16
+0.020
+1.75%
華盛通- 最 高1.16
- 今 開1.14
- 成交量 3.92万股
- 最 低 1.12
- 昨 收 1.14
- 總市值 7262.81万
- 52周最高 1.61
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 0.7101
- 委 比 -23.84%
- 總股本 6261.04万
- 歷史最高 15.24
- 量 比 0.27
- 振 幅 3.51%
- 歷史最低 0.70
- 每 手 1
- 風險率 0.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Insights Ahead: Myomo's Quarterly Earnings
Myomo (AMEX:MYO) is preparing to release its quarterly earnings on Monday, 2025...
08-09 04:05
Demystifying CytoSorbents: Insights From 5 Analyst Reviews
5 analysts have shared their evaluations of CytoSorbents (NASDAQ:CTSO) during t...
08-08 21:02
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.
08-08 20:28
CytoSorbents Q2 Adj. EPS $(0.05), Inline, Sales $9.62M Miss $9.80M Estimate
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 37.5 percent increase over losses of $(0.08) per share from the same period last year. The
08-08 04:13
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts
5 analysts have expressed a variety of opinions on CytoSorbents (NASDAQ:CTSO) o...
07-22 06:01
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
07-02 19:00
美股大行评级 | 潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级；联邦快递遭多家机构下调目标价>>
06-26 08:38
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings)
Ratings for CytoSorbents (NASDAQ:CTSO) were provided by 6 analysts in the past ...
06-25 21:00
